Intra-arterial Bone-marrow Mononuclear Cells Infusion for Acute Ischemic Stroke
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This trial aims to test that intra-arterial injection of autologous bone marrow mononuclear
cells in acute ischemic stroke patients is safe and improves neurological outcomes.